# Immune System & Immunology & Rheumatology

## Secondary Lymphoid Tissues

![](../Figures/Secondary%20Lymphoid%20Tissues.png)

## Macrophages

|Name|Site|
|-|-|
|Microglia|Brain|
|Alveolar macrophage|Lung|
|Kupffer cell|Liver|
|Mesangial cell|Kidney|
|Osteoclast|Bone|
|Histiocyte|Connective tissue|

## Leukocyte Extravasation & Phagocytosis

|Step|Endothelium|Leukocyte|Disease|
|-|-|-|-|
|Rolling|Selectin|SLX|-|
|Adhesion|CAM|Integrin|Leukocyte adhesion deficiency|
|Diapedesis|PECAM-1 (CD31)|PECAM-1 (CD31)|-|
|Migration|C5a & IL-8|-|-|
|Phagocytosis|-|-|-|
|Fusion|-|Microtubule|Chediak-Higashi syndrome|
|Degradation|-|NADPH oxidase|Chronic granulomatous disease|
||-|Myeloperoxidase|Myeloperoxidase deficiency|

## Toll-Like Receptors (TLR) on Antigen-Presenting Cells (APC)

![](../Figures/Toll-Like%20Receptors%20(TLR)%20on%20Antigen-Presenting%20Cells%20(APC).png)

## Complement Systems

|Pathway|Targets|Cascade|
|-|-|-|
|Classic pathway|Antigen-antibody complexes|142356789|
|Alternative pathway|Spontaneous and microbial surfaces|3BD356789|
|Lectin pathway|Microbial surfaces|M42356789|

![](../Figures/Complement%20Systems.png)

## Respiratory [Oxidative] Burst

![](../Figures/Respiratory%20Burst%20(Oxidative%20Burst).png)

## Functions of Complements & Cytokines

|Component|Functions|
|-|-|
|C3a ~ C5a|Anaphylaxis|
|C5a|Chemotaxis|
|C3b|Opsonization|
|C5b ~ C9b|Membrane attack complex (MAC)|
|IL-1|Fever|
|IL-2|T cell growth|
|IL-3|Bone marrow growth|
|IL-4|IgE production|
|IL-5|IgA production|
|IL-6|Acute-phase protein production|
|IL-8|Chemotaxis|

## Cytokine Secretion & Interactions

![](../Figures/Cytokine%20Secretion%20&%20Interactions.png)

## Cytokine Secretion

|Mechanism|Cell|Cytokines|
|-|-|-|
|General|Neutrophil|-|
|Cellular :: adaptive|Th1 cell|IL-2 & IL-3 & IL-12 & TNF-α & IFN-γ|
||Tc cell|IL-2 & IL-3 & TNF-α|
|Cellular :: innate|Macrophage|IL-1 & IL4 & IL-6 & IL-8 & IL-12 & TNF-α|
||NK cell|IL-2 & TNF-α & IFN-γ|
|Humoral :: adaptive|Th2 cell|IL-2 & IL-3 & IL-4 & IL-5 & IL-6 & IL-10|
||B cell|-|
|Humoral :: innate|Basophil|IL-4 & IL-5|
||Eosinophil|-|

## Cytokine Interactions

|Mechanism|Cell|Inducers|Inhibitors|
|-|-|-|-|
|General|Neutrophil|IL-1 & IL-6 & IL-8|IL-10 & TGF-β|
|Cellular :: adaptive|Th1 cell|IL-2 & IL-12|IL-4 & IL-10|
||Tc cell|IL-2 & IL-12|-|
|Cellular :: innate|Macrophage|IFN-γ|-|
||NK cell|IL-2 & IL-12 & IFN-γ|-|
|Humoral :: adaptive|Th2 cell|IL-2 & IL-4|IFN-γ|
||B cell|IL-3 & IL-4 & IL-5 & IL-6|-|
|Humoral :: innate|Basophil|IL-3 & IL-5|-|
||Eosinophil|IL-5|-|

## Cell Surface Proteins

|Mechanism|Cell|Signal 1|Signal 2|Others|
|-|-|-|-|-|
|General|Neutrophil|-|-|-|
|Cellular :: adaptive|Th1 cell|TCR & CD3 & CD4|CD28 & CD40L|-|
||Tc cell|TCR & CD3 & CD8|CD28|-|
|Cellular :: innate|Macrophage|MHC-1 & MHC-2|B7 & CD40|CD14|
||NK cell|-|-|CD16 & CD56|
|Humoral :: adaptive|Th2 cell|TCR & CD3 & CD4|CD28 & CD40L|-|
||B cell|MHC-1 & MHC-2|B7 & CD40|CD19 & CD20 & CD21|
|Humoral :: innate|Basophil|-|-|-|
||Eosinophil|-|-|-|

## Structure of MHC

![](../Figures/Structure%20of%20MHC.png)

## Structure of Lymphocyte Receptors

![](../Figures/Structure%20of%20Lymphocyte%20Receptors.png)

## Development of Lymphocytes

![](../Figures/T%20Cell%20Development.png)
![](../Figures/B%20Cell%20Development.png)

## Activation of Lymphocytes

![](../Figures/Activation%20of%20Lymphocytes.png)

## Immunoglobulins {MDGEA}

|Immunoglobulin|Members|
|-|-|
|IgM|5|
|IgD|1|
|IgG|1|
|IgE|1|
|IgA|2|

## Mechanisms of Antibody Diversity

|Mechanism|Enzymes|
|-|-|
|N-nucleotide addition|Terminal deoxynucleotidyl transferase (TdT)|
|Random recombination of VJ or VDJ genes|RAG-1 & RAG-2|
|Random combination of heavy and light chains|-|
|Somatic hypermutation|-|

## Hypersensitivity

### Type 1

|Disease|Defects|
|-|-|
|Allergy|IgE|
|Transfusion reaction :: allergic|IgE|

### Type 2

|Disease|Defects|
|-|-|
|Autoimmune hemolytic anemia (AHA)|Anti-RBC|
|Bullous pemphigoid|Anti-hemidesmosome|
|Goodpasture syndrome|Anti-basement membrane|
|Graves disease|Anti-TSH receptor|
|Guillain-Barre syndrome|Anti-ganglioside|
|Heparin-induced thrombocytopenia (HIT)|Anti-platelet factor 4 (Anti-PF4)|
|Immune thrombocytopenic purpura (ITP)|Anti-Gp1b & Anti-Gp2b/3a|
|Lambert-Eaton myasthenic syndrome|Anti-presynatic Ca channel|
|Myasthenia gravis|Anti-ACh receptor|
|Pemphigus vulgaris|Anti-desmosome|
|Pernicious anemia|Anti-parietal cell|
|Rheumatic fever|Anti-M protein|
|Transfusion reaction :: acute hemolytic (AHTR)|Anti-ABO & Anti-Rh|
|Transplant reaction :: hyperacute|-|

### Type 3

|Disease|Defects|
|-|-|
|Vasculitis :: granulomatosis with polyangiitis (GPA)|PR3-ANCA [c-ANCA]|
|Vasculitis :: eosinophilic granulomatosis with polyangiitis (EGPA)|MPO-ANCA [p-ANCA]|
|Vasculitis :: microscopic polyangiitis|MPO-ANCA [p-ANCA]|
|Antiphospholipid syndrome (APS)|Anti-cardiolipin & Anti-β2-glycoprotein I & Lupus anticoagulant|
|Arthus reaction|-|
|Autoimmune hepatitis|Anti-smooth muscle|
|Dermatitis herpetiformis|Anti-tissue transglutaminase (Anti-tTG) IgA|
|Drug-induced lupus|Anti-histone|
|Henoch-Schonlein purpura (HSP)|IgA|
|Membranoproliferative glomerulonephritis|C3 nephritic factor|
|Mixed connective tissue disease (MCTD)|Anti-U1 RNP|
|Polyarteritis nodosa|-|
|Polymyositis & Dermatomyositis|Anti-Jo-1 & Anti-Mi-2 & Anti-SRP|
|Primary biliary cirrhosis (PBC)|Anti-mitochondrium|
|Rheumatoid arthritis|Rheumatoid factor [Anti-IgG] & Anti-CCP|
|Scleroderma :: diffuse|Anti-Scl-70 [Anti-topoisomerase]|
|Scleroderma :: limited|Anti-centromere|
|Serum sickness|-|
|Sjogren syndrome|Anti-Ro [Anti-SSA] & Anti-La [Anti-SSB]|
|Systemic lupus erythematosus (SLE)|Anti-dsDNA & Anti-Smith [Anti-snRNP]|

### Type 4

|Disease|Defects|
|-|-|
|Celiac disease|Anti-tissue transglutaminase (Anti-tTG) IgA|
|Contact dermatitis|-|
|DM type 1|Anti-glutamate decarboxylase (Anti-GAD-65)|
|Graft-versus-host disease (GVHD)|-|
|Hashimoto thyroiditis|Anti-thyroglobulin & Anti-TPO & Anti-microsome|
|Multiple sclerosis|-|
|PPD skin test|-|
|Transplant reaction :: acute & chronic|-|

## HLA Subtypes Associated With Diseases

|HLA|Diseases|
|-|-|
|A3|Hemochromatosis|
|B27|Psoriatic arthritis & Ankylosing spondylitis & Inammatory bowel disease & Reactive arthritis|
|B5801|Stevens-Johnson syndrome (SJS)|
|DQ2 & DQ8|Celiac disease|
|DR2|Multiple sclerosis & Hay fever & SLE & Goodpasture syndrome|
|DR3|DM type 1 & SLE & Graves disease & Hashimoto thyroiditis|
|DR4|Rheumatoid arthritis & DM type 1|
|DR5|Pernicious anemia & Hashimoto thyroiditis|

## Immunodeficiency {WASH-CHILD-CBS}

### Combined Deficiency {WASH}

|Disease|Defects|Genetics|IgM|IgG|IgE|IgA|
|-|-|-|-|-|-|-|
|Wiskott-Aldrich syndrome (WAS)|Actin cytoskeleton reorganization|WAS|↓|-|↑|↑|
|Ataxia telangiectasia|Serine/Threonine kinase (STK)|ATM|-|↓|↓|↓|
|Severe combined immunodeficiency (SCID) :: AR|Adenosine deaminase|ADA|↓|↓|↓|↓|
|Severe combined immunodeficiency (SCID) :: XR|IL-2R|IL-2R|↓|↓|↓|↓|
|Hyper-IgM syndrome|CD40L|CD40L|↑|↓|↓|↓|

### T Cell Deficiency {CHILD}

|Disease|Defects|Genetics|IgM|IgG|IgE|IgA|
|-|-|-|-|-|-|-|
|Chronic mucocutaneous candidiasis|-|-|-|-|-|-|
|Hyper-IgE [Job] syndrome|-|STAT3|-|-|↑|-|
|IL-12R deficiency|IL-12R|IL-12R|-|-|-|-|
|DiGeorge syndrome|Thymus & Parathyroid|22q11|-|-|-|-|

### B Cell Deficiency {CBS}

|Disease|Defects|Genetics|IgM|IgG|IgE|IgA|
|-|-|-|-|-|-|-|
|Common variable immunodeficiency (CVID)|-|-|↓|↓|↓|↓|
|Bruton agammaglobulinemia|Bruton tyrosine kinase|BTK|↓|↓|↓|↓|
|Selective IgA deficiency|-|-|-|-|-|↓|

## Presentation of Wiskott-Aldrich syndrome (WAS) {WATER}

- Wiskott
- Aldrich
- Thrombocytopenia
- Eczema ← ↑ IgE & IgA
- Recurrent infection

## Presentation of Sarcoidosis {SHARING}

- Schaumann body
- Hypercalcemia
- ↑ 1α-hydroxylase
- ↑ Angiotensin converting enzyme (ACE)
- Asteroid body
- Rheumatoid arthritis
- Interstitial fibrosis
- Noncaseating granuloma
- γ globulinemia

## Seronegative Spondyloarthropathy {PAIR}

- Psoriatic arthritis
- Ankylosing spondylitis
- Inflammatory bowel disease
- Reactive arthritis [Reiter syndrome]

## Triad of Reactive Arthritis {AUC}

- Arthritis
- Urethritis
- Conjunctivitis

## SLICC Diagnostic Criteria for SLE {MD-SOAP-BRAIN}

- Malar rash
- Discoid rash
- Serositis
- Oral ulcer
- Arthritis
- Photosensitivity
- Blood disorders
- Renal disorders
- Autoimmune antibody
- Immunologic disorders
- Neurologic disorders

## Diagnostic Criteria for Rheumatoid Arthritis

- Polyarthritis :: joints ≥ 3
- Chronicity :: duration > 6 weeks
- Positive RF / Anti-CCP
- Elevated ESR / CRP
- Exclusion of alternative diagnoses

## Presentation of Limited Scleroderma {CREST}

- Calcinosis
- Raynaud syndrome
- Esophageal dysmotility
- Sclerodactyly
- Telangiectasia

## Presentation of Henoch-Schonlein Purpura

- Arthritis
- Rashes
- Abdominal pain

## Presentation of Dermatomyositis

- Gottron sign
- Heliotrope sign
- Gower sign
- Proximal muscle weakness

## Diagnostic Criteria for Antiphospholipid Syndrome

- Clinical criteria ≥ 1
	- Vascular thrombosis
	- Pregnancy morbidity
		- Unexplained fetal death > 10 weeks of gestation
		- Premature births of due to eclampsia / placental insufficiency
		- Three unexplained consecutive spontaneous abortions < 10 weeks of gestation
- Laboratory criteria ≥ 1
	- Lupus anticoagulant at least twice > 12 weeks apart
	- Anti-cardiolipin at least twice > 12 weeks apart
	- Anti-β<sub>2</sub> glycoprotein at least twice > 12 weeks apart

## Presentation of Adult-onset Still's Disease

- Arthralgia
- Fever
- Ferritin increased
- Hepatomegaly
- Leukocytosis
- Lymphadenopathy
- Rashes salmon-colored & non-pruritic
- Splenomegaly

## Mechanisms of Action of Immunosuppressants

![](../Figures/Mechanisms%20of%20Action%20of%20Immunosuppressants.png)

## Mechanisms of Action of Immunosuppressants

|Mechanism|Medication|Indications|
|-|-|-|
|NF-κB inhibitors|Steroids|Immunosuppression|
|Calcineurin inhibitors|Cyclosporine|Immunosuppression|
||Tacrolimus|Immunosuppression|
|mTOR inhibitors|Sirolimus|Immunosuppression|
||Everolimus|Immunosuppression|
|Purine synthesis inhibitors|Mycophenolate|Immunosuppression|
||Azathioprine|Immunosuppression|
|Pyrimidine synthesis inhibitors|Leflunomide|Immunosuppression|
|IL-2R inhibitors|Basiliximab|Immunosuppression|
||Daclizumab|Immunosuppression|
|TNF-α inhibitors|Etanercept|Immunosuppression|
||Infliximab|Immunosuppression|
||Adalimumab|Immunosuppression|
|CD20 inhibitors|Retuximab|Immunosuppression|
